ImmunoPrecise Antibodies Ltd. (IPA)
USD 0.46
(-0.71%)
USD 0.46
(-0.71%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 24.51 Million | 20.66 Million | 19.36 Million | 17.91 Million | 14.05 Million | 10.92 Million |
| Cost of Revenue | 12.46 Million | 9.1 Million | 8.38 Million | 6.37 Million | 6.02 Million | 5.63 Million |
| Gross Profit | 12.05 Million | 11.56 Million | 10.98 Million | 11.53 Million | 8.03 Million | 5.29 Million |
| Operating Expenses | 25.81 Million | 39.78 Million | 27.15 Million | 15.71 Million | 12.08 Million | 11.51 Million |
| Selling, General and Administrative Expenses | 19.13 Million | 23.42 Million | 17.71 Million | 13.33 Million | 8.32 Million | 8.46 Million |
| Research and Development Expenses | 4.04 Million | 12.28 Million | 6.69 Million | 1.97 Million | 446.28 Thousand | 485.84 Thousand |
| Other Expenses | 2.63 Million | - | 2.75 Million | 132 Thousand | 2.65 Million | 1.91 Million |
| Cost and Expenses | 38.28 Million | 48.88 Million | 35.53 Million | 22.08 Million | 18.1 Million | 17.15 Million |
| Operating Income | -13.76 Million | -26.09 Million | -15.78 Million | -6.65 Million | -4.09 Million | -6.22 Million |
| Interest Expense | 19 Thousand | 30 Thousand | 419 Thousand | 863 Thousand | 1.43 Million | 1.31 Million |
| Income Tax Expense | -1.52 Million | -1.19 Million | 861 Thousand | 1.34 Million | -345.72 Thousand | 4788.00 |
| Earnings before Tax | -28.7 Million | -27.75 Million | -15.84 Million | -5.99 Million | -5.29 Million | -7.61 Million |
| Net Income | -27.17 Million | -26.56 Million | -16.7 Million | -7.34 Million | -4.94 Million | -7.61 Million |
| Earnings Per Share Basic | -1.06 | -1.07 | -0.85 | -0.45 | -0.36 | -0.61 |
| Earnings Per Share Diluted | -1.06 | -1.07 | -0.85 | -0.45 | -0.36 | -0.61 |
| Weighted Average Shares Outstanding | 25.63 Million | 24.89 Million | 19.68 Million | 16.47 Million | 13.62 Million | 12.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.63 Million | 24.89 Million | 19.68 Million | 16.47 Million | 13.62 Million | 12.54 Million |
| Gross Margin | 0.49 | 0.56 | 0.57 | 0.64 | 0.57 | 0.48 |
| EBIT Margin | -0.94 | -1.03 | -0.63 | -0.01 | -0.03 | -0.36 |
| Profit Margin | -1.11 | -1.29 | -0.86 | -0.41 | -0.35 | -0.70 |
| EBITDA | -22.94 Million | -21.03 Million | -11.99 Million | -1.41 Million | -449 Thousand | -4.03 Million |
| Earnings Before Tax Margin | -0.56 | -1.26 | -0.81 | -0.37 | -0.29 | -0.57 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 5.26 Million | 6.45 Million | 24.51 Million | 6.22 Million | 6.15 Million | 4.68 Million |
| Cost of Revenue | 2.9 Million | 3.35 Million | 12.46 Million | 3.02 Million | 3.19 Million | 2.21 Million |
| Gross Profit | 2.35 Million | 3.1 Million | 12.05 Million | 3.19 Million | 2.95 Million | 2.47 Million |
| Operating Expenses | 6.98 Million | 6.62 Million | 25.81 Million | 6.53 Million | 5.96 Million | 12.22 Million |
| Selling, General and Administrative Expenses | 4.88 Million | 5.02 Million | - | 4.82 Million | 4.22 Million | 5.23 Million |
| Research and Development Expenses | 1.64 Million | 927 Thousand | - | 1 Million | 1.03 Million | 5.77 Million |
| Other Expenses | 7.12 Million | - | - | - | - | 1.2 Million |
| Cost and Expenses | 9.89 Million | 9.97 Million | 38.28 Million | 9.56 Million | 9.15 Million | 14.43 Million |
| Operating Income | -4.62 Million | -3.85 Million | -13.73 Million | -3.34 Million | -2.79 Million | -9.74 Million |
| Interest Expense | 2000.00 | 4000.00 | 19 Thousand | 5000.00 | 5000.00 | 50 Thousand |
| Income Tax Expense | -776 Thousand | -777 Thousand | -1.52 Million | -517 Thousand | 32 Thousand | -403 Thousand |
| Earnings before Tax | -4.77 Million | -18.82 Million | -28.7 Million | -3.45 Million | -2.59 Million | -9.78 Million |
| Net Income | -3.99 Million | -18.04 Million | -27.17 Million | -2.94 Million | -2.62 Million | -9.38 Million |
| Earnings Per Share Basic | -0.16 | -0.67 | - | -0.11 | -0.10 | -0.38 |
| Earnings Per Share Diluted | -0.16 | -0.67 | - | -0.11 | -0.10 | -0.38 |
| Weighted Average Shares Outstanding | 25.6 Million | 26.94 Million | 25.63 Million | 25.8 Million | 25.05 Million | 24.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.6 Million | 26.94 Million | 25.63 Million | 25.8 Million | 25.05 Million | 24.73 Million |
| Gross Margin | 0.45 | 0.48 | 0.49 | 0.51 | 0.48 | 0.53 |
| EBIT Margin | -0.61 | -0.35 | - | -0.33 | -0.23 | -1.75 |
| Profit Margin | -0.76 | -2.79 | -1.11 | -0.47 | -0.43 | -2.00 |
| EBITDA | -3.23 Million | -2.27 Million | - | -2.02 Million | -1.44 Million | -8.19 Million |
| Earnings Before Tax Margin | -0.88 | -0.60 | -0.56 | -0.54 | -0.45 | -2.08 |
6498
122990
HUMBLE
MNRA
348210
KORDS